Doximity Faces Securities Lawsuit Over Alleged Market Share Misstatements

The litigation targets the period between August 8, 2024, and May 13, 2026, following a series of sharp stock price declines. Investors allege that while Doximity publicly projected confidence in its ability to capture market share, the company was actually conceding ground to competitors with more aggressive pricing and engagement models. The suit centers on a November 2024 earnings call, where Nate Gross asserted that the firm felt positive about its competitive positioning and product quality.

The Legal Claims Against Executives

The complaint asserts that these public assurances were materially misleading, particularly as Doximity relied on engagement formats that conflicted with its stated rejection of traditional banner advertising. Beyond the company itself, the lawsuit names Gross and other top executives as controlling persons under Section 20(a) of the Securities Exchange Act. Plaintiffs argue that Gross, who served as Chief Strategy Officer until June 2025, held the authority to oversee the accuracy of the company’s SEC filings and analyst presentations. Shareholders experienced significant losses, including a 13% drop on November 7, 2025, followed by further declines of 17% and 23% in early 2026. The deadline for investors to apply as lead plaintiff is November 16, 2026.